Literature DB >> 17855740

Management of atrial fibrillation in patients with heart failure.

Hans-Ruprecht Neuberger1, Christian Mewis, Dirk J van Veldhuisen, Ulrich Schotten, Isabelle C van Gelder, Maurits A Allessie, Michael Böhm.   

Abstract

Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in patients with CHF. This review summarizes current literature concerning the following topics: (i) prognostic relevance of AF in patients with CHF, (ii) relevance and strategies of rhythm and rate control in patients with AF and CHF, and (iii) options for prevention of AF in patients with ventricular dysfunction. In conclusion, AF is associated with increased mortality in CHF patients. However, it is not clear whether there is a causal relationship. Emerging strategies to prevent the occurrence of AF are promising tools that might improve quality of life and survival in patients with CHF.

Entities:  

Mesh：

Year:  2007        PMID： 17855740     DOI： 10.1093/eurheartj/ehm341

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  23 in total

1.  Procollagen propeptides: serum markers for atrial fibrosis?

Authors:  Hans-Ruprecht Neuberger; Angela Cacciatore; Jan-Christian Reil; Stefan Gräber; Hans-Joachim Schäfers; Christian Ukena; Michael Böhm; Christian Mewis
Journal:  Clin Res Cardiol       Date:  2012-03-10       Impact factor: 5.460

Review 2.  Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

3.  Heart failure, aging and beta-blockers: the need for more data on tolerability and efficacy.

Authors:  Kevin Damman; Rudolf A de Boer; Dirk J van Veldhuisen
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

4.  Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Sunghee Kim; Gregg C Fonarow; Laine Thomas; Jack Ansell; Peter R Kowey; Kenneth W Mahaffey; Bernard J Gersh; Elaine Hylek; Gerald Naccarelli; Alan S Go; James Reiffel; Paul Chang; Eric D Peterson; Jonathan P Piccini
Journal:  Am Heart J       Date:  2014-02-17       Impact factor: 4.749

Review 5.  The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias.

Authors:  Xun Ai; Jiajie Yan; Elena Carrillo; Wenmao Ding
Journal:  Rev Physiol Biochem Pharmacol       Date:  2016       Impact factor: 5.545

Review 6.  Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.

Authors:  Stefano Bordignon; Maria Chiara Corti; Claudio Bilato
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 7.  Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Authors:  Parikshit S Sharma; David J Callans
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 8.  Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.

Authors:  Eleonora Grandi; Antony J Workman; Sandeep V Pandit
Journal:  J Atr Fibrillation       Date:  2012-04-14

9.  Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?

Authors:  Laurent Fauchier; Guillaume Laborie; Nicolas Clementy; Dominique Babuty
Journal:  Card Fail Rev       Date:  2016-05

10.  Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF.

Authors:  Antony J Workman; Davide Pau; Calum J Redpath; Gillian E Marshall; Julie A Russell; John Norrie; Kathleen A Kane; Andrew C Rankin
Journal:  Heart Rhythm       Date:  2008-12-31       Impact factor: 6.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.